Patents by Inventor CHANTAL MÉRETTE

CHANTAL MÉRETTE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220133209
    Abstract: Methods for the diagnosis, prognosis, patient stratification and prediction of pharmacological response in patients afflicted by psychiatric disorders based on electroretinography (ERG) parameters are described.
    Type: Application
    Filed: January 19, 2022
    Publication date: May 5, 2022
    Inventors: Marc Hebert, Michel Maziade, Chantal Mérette
  • Patent number: 11259738
    Abstract: Methods for the diagnosis, prognosis, patient stratification and prediction of pharmacological response in patients afflicted by psychiatric disorders based on electroretinography (ERG) parameters are described.
    Type: Grant
    Filed: November 15, 2019
    Date of Patent: March 1, 2022
    Assignee: Université Laval
    Inventors: Marc Hébert, Michel Maziade, Chantal Mérette
  • Publication number: 20200085338
    Abstract: Methods for the diagnosis, prognosis, patient stratification and prediction of pharmacological response in patients afflicted by psychiatric disorders based on electroretinography (ERG) parameters are described.
    Type: Application
    Filed: November 15, 2019
    Publication date: March 19, 2020
    Inventors: Marc Hébert, Michel Maziade, Chantal Mérette
  • Publication number: 20160029919
    Abstract: Methods for the diagnosis, prognosis, patient stratification and prediction of pharmacological response in patients afflicted by psychiatric disorders based on electroretinography (ERG) parameters are described.
    Type: Application
    Filed: March 13, 2014
    Publication date: February 4, 2016
    Inventors: MARC HEBERT, MICHEL MAZIADE, CHANTAL MERETTE
  • Publication number: 20150292016
    Abstract: Methods and kits for diagnosing a psychiatric disorder such as schizophrenia, schizo-affective disorder, bipolar disorder or Tourette syndrome, or a predisposition thereto, in a subject, are disclosed. The methods and kits are based on the detection of the presence of SNP rs1156026, and/or of deletions located in introns of the DNAJC15 gene, in a biological sample from the subject.
    Type: Application
    Filed: May 4, 2015
    Publication date: October 15, 2015
    Inventors: ALEXANDRE BUREAU, YVON CHAGNON, MICHEL MAZIADE, CHANTAL MÉRETTE, MARC-ANDRÉ ROY
  • Publication number: 20060134625
    Abstract: The present invention relates to methods for identifying the susceptibility or predisposition of an individual to schizophrenia SZ) or to clusters of symptoms associated thereof. Particularly, the tests can be performed before or after the disorders appear. More particularly, the present invention relates to the determination of epistatic effect of at least two genotype related loci. In addition, the invention provides tests for the classification of different subtypes predicting severity of illness of patients affected by or predisposed to SZ or associated clusters of symptoms.
    Type: Application
    Filed: February 19, 2004
    Publication date: June 22, 2006
    Inventors: Michel Maziade, Chantal Merette, Marc-Andre Roy